RecruitingNCT07439744
EPA omega-3 for depressive symptoms in people with obesity
About this title
Read the official source — NCT07439744This study assesses depression symptoms.
Placebo comparisonAges 18–54Taiwan
Understand this study
What is this study about?
This study assesses depression symptoms.
Who could participate?
Listed age limits: 18 years to 54 years.
- Listed locations
- TaichungSee all locations and recruitment
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: March 1, 2025
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 50
- Sponsor
- National Science and Technology Council, Taiwan
- Sponsor type
- Unknown or unclear
- Study type
- Other
- Intervention type
- Dietary supplement
- Locations
- Taiwan
- Age range
- From 18 Years to 54 Years
- Official registry ID
- NCT07439744
- Official title
Show the full official title
Effects of 12-week n-3 PUFA Treatment (EPA) on Depressive Symptoms in Overweight/Obese Depressed Subjects With Low n-3 PUFA Status: Relationship With Systemic Inflammation
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
Taichung
Interested in joining this study?
Questions about this study
What is this study about?
This study assesses depression symptoms.
Who is behind this study?
The study sponsor is National Science and Technology Council, Taiwan.
Who can participate?
Listed age limits: 18 years to 54 years.
Is this study still recruiting?
The registry lists this study as recruiting.
